Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration
暂无分享,去创建一个
A. Freemont | J. Hoyland | Judith A Hoyland | S. J. Millward-Sadler | Anthony J Freemont | S Jane Millward-Sadler | Patrick W Costello | J. Millward-Sadler | P. Costello
[1] D. Polly,et al. Surgical Treatment for the Painful Motion Segment: Matching Technology With the Indications: Posterior Lumbar Fusion , 2005, Spine.
[2] P. Roux‐Lombard,et al. Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications. , 1995, Arthritis and rheumatism.
[3] T. Mak,et al. Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1. , 2001, Clinical immunology.
[4] M. Feldmann,et al. INHIBITORY EFFECT OF TNFα ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS , 1989, The Lancet.
[5] J. Dayer,et al. Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis , 1995 .
[6] G. R. Dodge,et al. Effects of interleukin-1β and tumor necrosis factor-α on expression of matrix-related genes by cultured equine articular chondrocytes , 2000 .
[7] N. Boos,et al. Expression and Distribution of Tumor Necrosis Factor Alpha in Human Lumbar Intervertebral Discs: A Study in Surgical Specimen and Autopsy Controls , 2005, Spine.
[8] A. Freemont,et al. The role of interleukin-1 in the pathogenesis of human Intervertebral disc degeneration , 2005, Arthritis research & therapy.
[9] N. Boos,et al. Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. , 2007, Annals of the New York Academy of Sciences.
[10] M. Nagino,et al. Phosphorylation of extracellular signal‐regulated kinase 1/2, p38 mitogen‐activated protein kinase and nuclear translocation of nuclear factor‐κB are involved in upregulation of matrix metalloproteinase‐9 by tumour necrosis factor‐α , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[11] M. Feldmann,et al. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Dayer,et al. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[13] J. Hoyland,et al. Human disc degeneration is associated with increased MMP 7 expression , 2006, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[14] A. Freemont,et al. Catabolic cytokine expression in degenerate and herniated human intervertebral discs: IL-1β and TNFα expression profile , 2007, Arthritis research & therapy.
[15] Max Aebi,et al. Immunolocalization of major interstitial collagen types in human lumbar intervertebral discs of various ages , 1998, Virchows Archiv.
[16] P. Roughley,et al. Tumor Necrosis Factor&agr; Modulates Matrix Production and Catabolism in Nucleus Pulposus Tissue , 2005, Spine.
[17] A. Freemont,et al. Matrix synthesis and degradation in human intervertebral disc degeneration. , 2007, Biochemical Society transactions.
[18] A. Freemont,et al. Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study , 2007, Arthritis research & therapy.
[19] A. Nachemson,et al. Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. , 1975, Journal of anatomy.
[20] L. Joosten,et al. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra. , 1996 .
[21] M. Tortorella,et al. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. , 2001, Osteoarthritis and cartilage.
[22] R. Kinne,et al. Preferential induction of prodestructive matrix metalloproteinase-1 and proinflammatory interleukin 6 and prostaglandin E2 in rheumatoid arthritis synovial fibroblasts via tumor necrosis factor receptor-55. , 2003, The Journal of rheumatology.
[23] L. Setton,et al. Intervertebral Disc Cells Exhibit Differences in Gene Expression in Alginate and Monolayer Culture , 2001, Spine.
[24] F. Nielsen,et al. Diverging mechanisms for TNF‐α receptors in normal mouse brains and in functional recovery after injury: From gene to behavior , 2007, Journal of neuroscience research.
[25] N. Boos,et al. 2002 SSE Award Competition in Basic Science: Expression of major matrix metalloproteinases is associated with intervertebral disc degradation and resorption , 2002, European Spine Journal.
[26] A. Freemont,et al. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. , 2008, Rheumatology.
[27] V. Lefebvre,et al. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. , 1991, Biochimica et biophysica acta.
[28] A. Gray,et al. The economic burden of back pain in the UK , 1999, Pain.
[29] G. R. Dodge,et al. Effects of interleukin-1beta and tumor necrosis factor-alpha on expression of matrix-related genes by cultured equine articular chondrocytes. , 2000, American Journal of Veterinary Research.
[30] A. Freemont,et al. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs , 2002, Molecular pathology : MP.
[31] A. Freemont,et al. A preliminary in vitro study into the use of IL‐1Ra gene therapy for the inhibition of intervertebral disc degeneration , 2006, International journal of experimental pathology.
[32] N. Boos,et al. Analysis of Tissue Distribution of TNF‐α, TNF‐α‐Receptors, and the Activating TNF‐α–Converting Enzyme Suggests Activation of the TNF‐α System in the Aging Intervertebral Disc , 2007 .
[33] A. Freemont,et al. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc , 2004, The Journal of pathology.
[34] S. Jang,et al. mRNA Expression of Cytokines and Chemokines in Herniated Lumbar Intervertebral Discs , 2002, Spine.
[35] H. Towbin,et al. Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. , 1993, Clinical and experimental rheumatology.
[36] L. Joosten,et al. Amelioration of established murine collagen‐induced arthritis with anti‐IL‐1 treatment , 1994, Clinical and experimental immunology.